Sprimeo er undersøgt i 1. 864 patienter i alderen 65 år eller derover og i 426 patienter i alderen 75 år eller derover.
Sprimeo has been studied in 1,864 patients aged 65 years or older, and in 426 patients aged 75 years or older.